Nagendra Prasad is specialized in cancer cell biology with an in-depth experience in drug discovery and translational research. He started his training as a Doctor of Veterinary Medicine and later obtained a PhD in Medicine from Memorial University of Newfoundland, Canada. He moved then to Paris, France for post-doctoral research before arriving in the United States. His professional experience includes cancer and diabetes drug discovery and development research in Parke-Davis/Pfizer Research Labs, Ann Arbor, MI. As a faculty member at Purdue University, he established an independent research program on signaling pathways linking breast cancer and obesity/high fat diet. His main focus of research is inositol phosphatases and their role in cell adhesion and growth factor signaling pathways. Currently he is the Director of a translational research facility at the Indiana University Simon Cancer Center, Indiana University School of Medicine (Indianapolis, IN) where he focuses on transforming cutting edge basic science discoveries in cancer genetics and signaling mechanisms into useful clinical practices to benefit cancer patients.
